<p>IQR, interquartile range; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, non-nucleoside reverse transcriptase inhibitors; PIs, protease inhibitors; N/A, not available; NA, not applicable.</p
<p>IQR: interquartile range.</p>*<p>Statistical significant difference (p<0.05) was observed among t...
<p>BMI: Body mass index; SD: Standard deviation; NNRTI: Non-nucleoside reverse transcriptase inhibit...
<p>General and disease-specific characteristics of patient groups. Abbreviations: <b>ALT</b>, alanin...
<p>IQR: interquartil range; ART: antiviral therapy; PI: protease inhibitor; NRTI: nucleoside reverse...
<p>N: number of patients, IQR: interquartile range, NRTI: nucleoside reverse transcriptase inhibitor...
<p>*) Paired t-test or Related sample McNemar's test when categorical variables. NRTI, nucleoside re...
<p>M: median. N(t)RTIs: nucleos(t)ide analogue reverse transcriptase inhibitors. NNRTI: nonnucleosid...
<p>Data are median (IQR) unless otherwise stated, IDU-intravenous drug use, Ab-antibody, SAg-surface...
<p><b>NOTE:</b> Data are median (IQR -Interquartile range-). FRs: Full Responders; INRs : Immunologi...
<p>TDR, transmitted drug resistance; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-n...
<p><sup>†</sup>median (interquartile range)</p><p>Nine patients were taking both PI/r and NNRTI, 1 p...
<p>OLA: oligonucleotide ligation assay; CS: consensus sequencing; IQR: interquartile range; NS: not ...
<p>f: Female; m: Male; NA; Not avaliable; Interquartile Range (IQR)</p><p>Clinical characteristics o...
<p><u>Footnote:</u> n, number; IQR, interquartile range; NRTI, nucleoside reverse transcriptase inhi...
†<p> Treatment status at the time of serum collection; ND: Not done; ART: Anti-retroviral therapy; N...
<p>IQR: interquartile range.</p>*<p>Statistical significant difference (p<0.05) was observed among t...
<p>BMI: Body mass index; SD: Standard deviation; NNRTI: Non-nucleoside reverse transcriptase inhibit...
<p>General and disease-specific characteristics of patient groups. Abbreviations: <b>ALT</b>, alanin...
<p>IQR: interquartil range; ART: antiviral therapy; PI: protease inhibitor; NRTI: nucleoside reverse...
<p>N: number of patients, IQR: interquartile range, NRTI: nucleoside reverse transcriptase inhibitor...
<p>*) Paired t-test or Related sample McNemar's test when categorical variables. NRTI, nucleoside re...
<p>M: median. N(t)RTIs: nucleos(t)ide analogue reverse transcriptase inhibitors. NNRTI: nonnucleosid...
<p>Data are median (IQR) unless otherwise stated, IDU-intravenous drug use, Ab-antibody, SAg-surface...
<p><b>NOTE:</b> Data are median (IQR -Interquartile range-). FRs: Full Responders; INRs : Immunologi...
<p>TDR, transmitted drug resistance; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-n...
<p><sup>†</sup>median (interquartile range)</p><p>Nine patients were taking both PI/r and NNRTI, 1 p...
<p>OLA: oligonucleotide ligation assay; CS: consensus sequencing; IQR: interquartile range; NS: not ...
<p>f: Female; m: Male; NA; Not avaliable; Interquartile Range (IQR)</p><p>Clinical characteristics o...
<p><u>Footnote:</u> n, number; IQR, interquartile range; NRTI, nucleoside reverse transcriptase inhi...
†<p> Treatment status at the time of serum collection; ND: Not done; ART: Anti-retroviral therapy; N...
<p>IQR: interquartile range.</p>*<p>Statistical significant difference (p<0.05) was observed among t...
<p>BMI: Body mass index; SD: Standard deviation; NNRTI: Non-nucleoside reverse transcriptase inhibit...
<p>General and disease-specific characteristics of patient groups. Abbreviations: <b>ALT</b>, alanin...
DOI
Add to ORKG